• PHP88 - CLINICAL ADDED VALUE ASSESSMENT OF ANTI-INFECTIVES FOR SYSTEMIC USE BY FRENCH TRANSPARENCY COMMITTEE IS CORRELATED WITH THE PUBLIC HEALTH BENEFIT

    Oct 1, 2018, 00:00

  • PMS82 - HOW DO HEALTH SYSTEM EMPLOYEES WITH ESTABLISHED MUSCULOSKELETAL COMPLAINTS DECIDE ON THEIR TREATMENT PATHWAY? A QUALITATIVE APPROACH

    Oct 1, 2018, 00:00

  • PCN37 - MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF APALUTAMIDE AND ENZALUTAMIDE IN THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

    Oct 1, 2018, 00:00

  • PMS45 - COST PER RESPONDER ANALYSIS FOLLOWING A 48-WEEK PSORIATIC ARTHRITIS TREATMENT WITH SECUKINUMAB VERSUS ADALIMUMAB FROM THE PORTUGUESE PAYER PERSPECTIVE

    Oct 1, 2018, 00:00

  • PMD70 - ECONOMIC EVALUATION OF THE BURDEN OF PREECLAMPSIA WITHIN AN ITALIAN REGIONAL HEALTH SERVICE

    Oct 1, 2018, 00:00

  • PMD184 - PO-SCORAD TOOL IN BLACK SKIN PATIENTS WITH ATOPIC DERMATITIS- CORRELATION WITH THE SCORAD

    Oct 1, 2018, 00:00

  • PSY83 - IMPACT OF DOSE ESCALATION ON AVERAGE COST AND COST-EFFECTIVENESS OF ANTI-TNF AND USTEKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN SWEDEN

    Oct 1, 2018, 00:00

  • PHP349 - THE EVOLUTION OF STANDARD MONITORING REGISTRIES IN THE ITALIAN MARKET

    Oct 1, 2018, 00:00

  • PMH5 - HELP-SEEKING BEHAVIOR AND RISK OF SUICIDE ATTEMPT IN HEAVY DRINKERS- RESULTS FROM A NATIONAL 3-YEAR LONGITUDINAL STUDY

    Oct 1, 2018, 00:00

  • PIH4 - HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH EXTREMELY PRETERM BIRTH IN THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PSY124 - COST OF ALLOGENEIC HSCT COMPLICATIONS IN BRAZIL- A DETERMINISTIC LINKAGE APPROACH FOCUSING ON PATIENTS WITH GVHD

    Oct 1, 2018, 00:00

  • PCV106 - EVALUATION OF PRICES AND SALES VOLUME OF CARDIO-VASCULAR MEDICINES IN COMMUNITY PHARMACIES

    Oct 1, 2018, 00:00

  • PRM244 - USING A PARAMETRIC APPROACH TO SIMULATE THE FREQUENCY OF MIGRAINE HEADACHE DAYS IN PATIENTS WITH CHRONIC MIGRAINE WITH DATA FROM THE REGAIN STUDY

    Oct 1, 2018, 00:00

  • PMS107 - THE EFFICACY OF ACTIVE STRETCHING TECHNIQUE AMONG PATIENTS WITH TYPE II DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • PCN15 - INVESTIGATION OF THE ASSOCIATION BETWEEN INCIDENT METFORMIN EXPOSURE AND NON-SMALL CELL LUNG CANCER DIAGNOSIS AMONG DIABETIC PATIENTS

    Oct 1, 2018, 00:00

  • PCN305 - NICE AND THE CANCER DRUGS FUND – CAN OBSERVATIONAL EVIDENCE INFORM FUNDING DECISIONS IN ONCOLOGY?

    Oct 1, 2018, 00:00

  • PDB71 - ASSESSING THE RELATIVE COST-EFFECTIVENESS OF EMPAGLIFLOZIN AND CANAGLIFLOZIN FOR THE TREATMENT OF TYPE 2 DIABETES PATIENTS WITH EXISTING CARDIOVASCULAR DISEASE IN THE UK

    Oct 1, 2018, 00:00

  • PCV78 - PHARMACOECONOMIC EVALUATION OF DIFFERENT DRUG TREATMENT ALTERNATIVES FOR HYPERTENSIVE PATIENTS AT A TERTIARY CARE HOSPITAL, BANGALORE, INDIA

    Oct 1, 2018, 00:00

  • PMS25 - COST COMPARISON OF OPEN, MINIMALLY INVASIVE AND GUIDE-WIRELESS MINIMALLY INVASIVE SURGERY TRANSFORAMINAL LUMBAR INTERBODY FUSION (GMIS/TLIF) INTERVENTION FOR LUMBAR DEGENERATIVE DISC DISEASE IN THE UK

    Oct 1, 2018, 00:00

  • PHP138 - CHANGES IN THE NUMBER OF MIDWIVES IN EUROPEAN COUNTRIES BETWEEN 2000-2015

    Oct 1, 2018, 00:00

  • PSY199 - WHAT ARE THE MOST VALUED PATIENT OUTCOMES REGARDING MEDICAL CARE FOR FRENCH PATIENTS WITH OBESITY? RESULTS FROM AN ONLINE PATIENT COMMUNITY (CARENITY.COM)

    Oct 1, 2018, 00:00

  • PRM258 - METHODOLOGICAL APPROACHES FOR CONDUCTING MATCHING-ADJUSTED INDIRECT COMPARISONS INVOLVING MULTIPLE RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2018, 00:00

  • PGI26 - COST SAVING ANALYSIS OF A COMMUNITY STOMA CARE SERVICE

    Oct 1, 2018, 00:00

  • PCN245 - WHAT DRUGS SHOULD BE IN THE FOCUS OF COMPLEX EVALUATION IN PATIENTS WITH BREAST CANCER IN MOSCOW

    Oct 1, 2018, 00:00

  • PIH7 - LONG-ACTING RECOMBINANT FSH (CORIFOLLITROPIN ALFA) VERSUS RECOMBINANT FSH AS ASSISTED REPRODUCTION TECHNIQUES IN THE MANAGEMENT OF INFERTILITY- A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2018, 00:00

  • PIN124 - ASSESSING THE VALUE OF NEW ANTIBIOTICS IN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) WITH A FOCUS ON SURGICAL SITE INFECTION (SSI)- A REVIEW OF THE EVIDENCE BASE

    Oct 1, 2018, 00:00

  • PRM2 - IDENTIFICATION OF DOSE-ESCALATION IN BIOLOGIC THERAPY BASED ON CLAIMS DATA- THE EXAMPLE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

    Oct 1, 2018, 00:00

  • PSY110 - PHARMACOECONOMICS OF DIFFERENT TREATMENTS FOR STEROID-REFRACTORY GRAFT VERSUS HOST REACTION- ANALYSIS OF TREATMENT RESULTS IN A SINGLE-CENTER STUDY

    Oct 1, 2018, 00:00

  • PRM263 - THE USE OF PRISMA STATEMENT IMPROVES THE REPORTING QUALITY OF META-ANALYSES PUBLISHED IN THE FIELD OF PSYCHOLOGY

    Oct 1, 2018, 00:00

  • PCN29 - CONTRIBUTING FACTORS TO LOWER EFFECTIVENESS OF ONCOLOGY DRUGS COMPARED TO THEIR EFFICACY IN CLINICAL TRIALS

    Oct 1, 2018, 00:00

  • PSS74 - PATIENT QUALITY OF LIFE AND SATISFACTION IN AN APREMILAST-TREATED PSORIASIS POPULATION- ANALYSIS OF 126 PATIENTS FROM THE APPRECIATE STUDY IN THE UNITED KINGDOM AND IRELAND

    Oct 1, 2018, 00:00

  • PND68 - COST-EFFECTIVENESS OF TERIFLUNOMIDE COMPARED TO INTERFERON BETA-1B FOR RELAPSING MULTIPLE SCLEROSIS PATIENTS IN CHINA

    Oct 1, 2018, 00:00

  • PND54 - A LONG TERM ANALYSIS OF THE CLINICAL AND COST EFFECTIVENESS OF GLATIRAMER ACETATE USING FINAL 10-YEAR RESULTS FROM THE UK MULTIPLE SCLEROSIS RISK SHARING SCHEME

    Oct 1, 2018, 00:00

  • PRM254 - ON SIMULATION OF TIME TO PROGRESSION AND DEATH BASED ON AGGREGATE PFS AND OS CURVES

    Oct 1, 2018, 00:00

  • PSY118 - RESOURCE USE AMONG BIOLOGICAL THERAPY INITIATORS WITH CROHN’S DISEASE IN FINLAND

    Oct 1, 2018, 00:00

  • PCN172 - COST-EFFECTIVENESS ANALYSIS OF ALECTINIB IN UNTREATED ALK-REARRANGED NSCLC ITALIAN PATIENTS

    Oct 1, 2018, 00:00

  • PHP319 - MANDATORY JOINT CLINICAL ASSESSMENT – WHAT IS THE ADDITIONAL INSIGHT FROM EU-NETHTA VS. EMA?

    Oct 1, 2018, 00:00

  • PHP317 - IDENTIFYING THE CHANGES REQUIRED IN HEALTH TECHNOLOGY ASSESSMENT SYSTEMS IF OUTCOMES ARE TO BE OPTIMIZED IN A DIGITAL WORLD WHERE PERSONALIZED DATA AND PRECISION MEDICINE COLLIDE

    Oct 1, 2018, 00:00

  • PSS63 - IDENTIFYING PATIENT PREFERENCES FOR GLAUCOMA TREATMENT- EVIDENCE FROM LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PRM269 - SYSTEMATIC LITERATURE REVIEW (SLR) EVALUATING QUALITY ASSESSMENT TOOLS (QAT)

    Oct 1, 2018, 00:00

  • PSY65 - REAL-WORLD DATA ANALYSIS OF US CLAIMS DATA ON COAGULATION FACTOR IX DISPENSATION AND EXPENDITURES IN PATIENTS WITH SEVERE HEMOPHILIA B- STANDARD HALF-LIFE VS. EXTENDED HALF-LIFE PRODUCTS

    Oct 1, 2018, 00:00

  • PMD106 - COST-EFFECTIVENESS OF LONG-LASTING INSECTICIDE-NETS FOR THE PREVENTION OF MALARIA IN RURAL AND URBAN MALARIOUS AREAS

    Oct 1, 2018, 00:00

  • PHP42 - EARLY ACCESS PROGRAMS- A COMPARISON BETWEEN FRANCE, GERMANY AND THE UNITED KINGDOM

    Oct 1, 2018, 00:00

  • PCV110 - TREATMENT WITH FREE TRIPLE COMBINATION THERAPY OF ATORVASTATIN, PERINDOPRIL, AMLODIPINE AND ATORVASTATIN IN PATIENTS WITH HYPERTENSION- A REAL-WORLD POPULATION STUDY IN ITALY.

    Oct 1, 2018, 00:00

  • PUK9 - NETWORK META-ANALYSIS OF TREATMENTS IN PREVIOUSLY UNTREATED ADVANCED OR METASTATIC RENAL-CELL CARCINOMA WITH INTERMEDIATE TO POOR PROGNOSIS

    Oct 1, 2018, 00:00

  • PMS80 - PSORIATIC ARTHRITIS PREVALENCE IN PSORITIC PATIENTS- BRAZIL, CHILE AND COLOMBIA CASES

    Oct 1, 2018, 00:00

  • PHP192 - HTA EDUCATIONAL NEEDS IN CENTRAL-EASTERN-SOUTH EUROPEAN (CESE) COUNTIRES – RESULTS OF JOC HTA PROJECT

    Oct 1, 2018, 00:00

  • PRM239 - DOES MATCHING ADJUSTED INDIRECT COMPARISON (MAIC) WORK? RESULTS FROM A SIMULATION STUDY

    Oct 1, 2018, 00:00

  • PCN386 - QUALITY OF LIFE OF CAREGIVERS OF CANCER PATIENTS BEFORE AND AFTER PATIENT ADMISSION TO AN INTENSIVE CARE UNIT

    Oct 1, 2018, 00:00

  • PRM139 - CHOOSING THE RIGHT SOFTWARE FOR HTA ECONOMIC MODELS- A COMPARISON OF FOUR PROGRAMMES RECOMMENDED BY THE NATIONAL INSTITUTE OF HEALTH AND CARE EXCELLENCE

    Oct 1, 2018, 00:00

  • PGI9 - SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY OF INFLIXIMAB BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS

    Oct 1, 2018, 00:00

  • PMU18 - UK EPIDEMIOLOGY AND CLINICAL BURDEN OF VACCINE-PREVENTABLE CHILDHOOD INFECTIOUS DISEASES- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PMD51 - COMPARISON OF COSTS AND OUTCOMES BETWEEN COBLATION TECHNOLOGY AND ELECTROCAUTERY FOLLOWING TONSILLECTOMY AND ADENOIDECTOMY PROCEDURES

    Oct 1, 2018, 00:00

  • PSY69 - THE BURDEN OF HYPERKALEMIA IN GERMANY – A CLAIMS DATABASE ANALYSIS

    Oct 1, 2018, 00:00

  • PND141 - CHARACTERISTICS AND MANAGEMENT OF MIGRAINE PATIENTS WHO HAVE FAILED PRIOR PREVENTIVE TREATMENT IN PORTUGAL

    Oct 1, 2018, 00:00

  • PRM75 - DEVELOPMENT OF MACHINE LEARNING BASED ABSTRACT DOCUMENT CLASSIFICATION FOR SUPPORTING SYSTEMATIC REVIEWS

    Oct 1, 2018, 00:00

  • PMH30 - MENTAL DISORDERS AND MAJOR DEPRESSION- THE ECONOMIC ANALYSIS OF SOCIAL SECURITY COSTS IN ITALY

    Oct 1, 2018, 00:00

  • PGI52 - DECREASED WORK PRODUCTIVITY AND INCREASED HEALTHCARE RESOURCE UTILISATION (HRU) AMONG PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) – RESULTS FROM A REAL WORLD EVIDENCE STUDY

    Oct 1, 2018, 00:00

  • PIH25 - BE AWARE OF PEDIATRIC MALNUTRITION AT ADMISSION! ECONOMIC CONSEQUENCES OF DIFFERENT HOSPITAL SCREENING AND NUTRITIONAL TREATMENT APPROACHES.

    Oct 1, 2018, 00:00

  • PCN5 - TREATMENTS OF RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER IN ROUTINE CLINICAL PRACTICE – A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PSY36 - CLINICAL BURDEN OF CHRONIC GRAFT VERSUS HOST DISEASE- A SYSTEMATIC LITERATURE REVIEW OF INCIDENCE AND DISEASE SEVERITY

    Oct 1, 2018, 00:00

  • PHP316 - EXPLORING BIOSIMILAR MARKET ACCESS CONSIDERATIONS ACROSS THE EU

    Oct 1, 2018, 00:00

  • PHP355 - THE FUTURE OF VALUE-BASED CONTRACTING FOR HIGH-COST INNOVATIVE THERAPIES- GLOBAL LESSONS FROM EUROPE AND THE US

    Oct 1, 2018, 00:00

  • PCN218 - PERSONALIZED THERAPY DEVELOPMENT IN NSCLC DEMONSTRATES INTERSECTION BETWEEN INNOVATION AND POSITIVE COVERAGE DECISIONS

    Oct 1, 2018, 00:00

  • PSS45 - A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.

    Oct 1, 2018, 00:00

  • PHP56 - EARLY ACCESS PROGRAMS- AN ANALYSIS SINCE THEIR ESTABLISHMENT IN ITALY

    Oct 1, 2018, 00:00

  • PIH14 - FACTORS ASSOCIATED WITH THE USE OF ANTIPYRETICS IN CHILDREN OF PARENTS IN A COHORT SAMPLE IN SAUDI ARABIA

    Oct 1, 2018, 00:00

  • PCN338 - THE EVOLUTION OF TREATMENT ALGORITHMS IN NON-SMALL-CELL LUNG CANCER- IMPLICATIONS FOR REIMBURSEMENTS IN ENGLAND

    Oct 1, 2018, 00:00

  • PND121 - UTILITIES ASSOCIATED WITH ATTRIBUTES OF MIGRAINE PREVENTIVE TREATMENTS- ROUTE OF ADMINISTRATION AND ADVERSE EVENTS

    Oct 1, 2018, 00:00

  • PMD9 - ANALYSIS OF DYSLIPIDEMIA AMONG PATIENTS WITH DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • CP4 - WEIGHTED AVERAGE CALCULATIONS FOR POPULATING COST-EFFECTIVENESS MODELS- HOW IGNORING THE MODEL’S CLINICAL PATHWAYS CAN SIGNIFICANTLY BIAS THE INCREMENTAL COST-EFFECTIVENESS RATIO (ICER)

    Oct 1, 2018, 00:00

  • PCN25 - ROLE OF PROGRESSION FREE SURVIVAL IN THE APPROVAL PROCESS AND EUROPEAN HTA ASSESSMENTS

    Oct 1, 2018, 00:00

  • PMD142 - WHAT DISCOURAGES ELDERLY USE OF INSULIN-INFUSION PUMPS IN JAPAN?

    Oct 1, 2018, 00:00

  • PSS37 - A SYSTEMATIC REVIEW OF THE METHODOLOGICAL QUALITY OF ECONOMIC STUDIES EVALUATING OPHTHALMIC DRUGS

    Oct 1, 2018, 00:00

  • PHP290 - IMPLICATIONS OF CONDITIONAL APPROVAL AND APPROVAL UNDER EXCEPTIONAL CIRCUMSTANCES BY THE EUROPEAN MEDICINES AGENCY ON NICE APPRAISALS

    Oct 1, 2018, 00:00

  • PCN203 - HEALTHCARE RESOURCE USE IN PATIENTS WITH END-STAGE ADVANCED CUTANEOUS T-CELL LYMPHOMA (CTCL)- RESULTS OF SEVEN SEMI-STRUCTURED INTERVIEWS ACROSS LEADING UK CENTRES

    Oct 1, 2018, 00:00

  • PMD10 - PREVALENCE OF UNCONTROLLED BLOOD PRESSURE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS

    Oct 1, 2018, 00:00

  • PIH48 - CAN OLDER USERS USE ELECTRONIC CLINICAL OUTCOME ASSESSMENTS (ECOA)?

    Oct 1, 2018, 00:00

  • PCN288 - HAS THE NEW NICE APPRAISAL PROCESS FOR ONCOLOGY DRUGS DELIVERED FASTER PATIENT ACCESS TO INNOVATIVE TREATMENTS?

    Oct 1, 2018, 00:00

  • PRM205 - A CRITIQUE OF YOUTUBE AS A DATA SOURCE FOR THE QUALITATIVE EXPLORATION OF PATIENT REPORTED INFORMATION ON ACUTE MYELOID LEUKEMIA.

    Oct 1, 2018, 00:00

  • PMU125 - EVALUATING THE INFLUENCE OF SHARED DECISION-MAKING ON PATIENTS' HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE GENERAL-OUTPATIENT CLINIC IN HONG KONG SAR, CHINA

    Oct 1, 2018, 00:00

  • PCN310 - SURVIVAL IN CANCER CLINICAL TRIALS- A COMPARISON OF EMA APPROVALS AND NICE RECOMMENDATIONS.

    Oct 1, 2018, 00:00

  • PMU57 - COST-EFFECTIVENESS OF VACCINATION STRATEGIES TO PREVENT INFECTIOUS DISEASES- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCN361 - HEALTH ECONOMIC VALUE PROPOSITIONS FOR SUBCUTANEOUS TRASTUZUMAB AND THEIR TRANSFERABILITY TO CENTRAL-EASTERN EUROPEAN COUNTRIES

    Oct 1, 2018, 00:00

  • PHP112 - DO PATIENTS KNOW ABOUT THEIR CHRONIC HEALTH PROBLEMS AND THE DRUGS THEY TAKE?

    Oct 1, 2018, 00:00

  • PCV89 - CLINICAL AND ECONOMIC BURDEN OF IRON DEFICIENCY IN PATIENTS WITH CHRONIC HEART FAILURE

    Oct 1, 2018, 00:00

  • PMD180 - THE VALUE TO WOMEN WITH OVARIAN CANCER OF GENE VARIANTS WITH KNOWN AND UNKNOWN SIGNIFICANCE- A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2018, 00:00

  • PIN83 - PHARMACOECONOMIC EVALUATION OF PUBLIC PROCUREMENT CRITERIA IN THE NATIONAL PNEUMOCOCCAL VACCINE IMMUNIZATION PROGRAM- SLOVENIA AS A CASE STUDY

    Oct 1, 2018, 00:00

  • PRM229 - THE CLUSTERED NATURE OF TRIAL-BASED ECONOMIC EVALUATIONS- DOES IT MATTER?

    Oct 1, 2018, 00:00

  • PHP197 - AN EVALUATION OF THE PERFORMANCE OF HOSPITAL PHARMACIES’ GROUP PURCHASING ORGANIZATION TO PROMOTE HEALTHCARE MANAGEMENT

    Oct 1, 2018, 00:00

  • PUK13 - THE TREATMENT OF IRON DEFICIENCY/ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE IN GERMANY – A CLAIMS DATABASE ANALYSIS

    Oct 1, 2018, 00:00

  • PRM149 - OPEN-SOURCE DISCRETE EVENT SIMULATION MODEL FOR MAJOR DEPRESSION DISORDER (MDD)- AN UPDATE SUITABLE FOR NEW GENERATION TREATMENT?

    Oct 1, 2018, 00:00

  • PMD90 - ECONOMIC EVALUATION OF THE IMMUNOCYTOCHEMISTRY TEST FOR THE SIMULTANEOUS QUALITATIVE DETECTION OF PROTEINS P16INKA AND KI-67 (CINTEC PLUS CYTOLOGY KIT®) IN CERVICAL TISSUE

    Oct 1, 2018, 00:00

  • PMH51 - HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG COMMUNITY-DWELLING SUBJECTS WITH SCHIZOPHRENIA TREATED WITH RBP-7000 IN A CLINICAL TRIAL SETTING OVER 12 MONTHS

    Oct 1, 2018, 00:00

  • PRM216 - AGREEMENT BETWEEN REVISED BRUNET-LÉZINE AND INTERGROWTH-21ST NEURODEVELOPMENTAL ASSESSMENTS

    Oct 1, 2018, 00:00

  • PCN234 - IMPACT OF BALDUZZI LAW (CNN CLASS) ON TIME TO MARKET AND ON PRICES FOR ONCOLOGY DRUGS IN ITALY

    Oct 1, 2018, 00:00

  • PHP310 - COMPARISON OF THE HEALTH TECHNOLOGY ASSESSMENT OFFICES OF HUNGARY AND POLAND BASED ON OBJECTIVE CRITERIA

    Oct 1, 2018, 00:00

  • PRS32 - IMPACT OF SEVERE ASTHMA IN FRANCE- A CLAIM DATABASE STUDY

    Oct 1, 2018, 00:00

  • PMD108 - COST-EFFECTIVENESS OF LEFT VENTRICULAR ASSIST DEVICES IN END STAGE HEART FAILURE USING STATE TRANSITION MODELLING BASED ON REGISTRY DATA

    Oct 1, 2018, 00:00

  • PRM143 - EXPLORING THE EFFECTS OF SUBSEQUENT LIFE EXTENDING TREATMENTS ON CANCER TRIAL ENPOINTS USING CLINICAL TRIAL SIMULATION

    Oct 1, 2018, 00:00

  • PCN210 - USING REAL WORLD DATA TO DETERMINE HEALTH SYSTEM COSTS OF A 5-YEAR NON-SMALL CELL LUNG CANCER COHORT

    Oct 1, 2018, 00:00

  • PCP9 - GENE THERAPY CRISIS- HOW WILL THE CURRENT PRODUCT PIPELINE AFFECT THE PHARMACEUTICAL INDUSTRY AND HEALTHCARE SYSTEMS?

    Oct 1, 2018, 00:00

  • PCN171 - A COST-UTILITY ANALYSIS OF FULVESTRANT VERSUS ANASTROZOLE AS FIRST-LINE THERAPY FOR OESTROGEN RECEPTOR-POSITIVE LOCALLY ADVANCED AND METASTATIC BREAST CANCER

    Oct 1, 2018, 00:00

  • PCN345 - HEALTH STATE UTILITIES IN METASTATIC NSCLC- A STUDY OF MULTIPLE IMMUNO-ONCOLOGY TRIALS

    Oct 1, 2018, 00:00

  • PIN93 - REAL-WORLD TIGECYCLINE USE IN CHINA FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAIS)

    Oct 1, 2018, 00:00

  • PMH16 - THE PRESCRIPTION PATTERNS OF SELECTIVE SEROTONIN (NOREPINEPHRINE) REUPTAKE INHIBITORS IN GERMANY

    Oct 1, 2018, 00:00

  • PMU105 - PATIENT PREFERENCES IN HEALTH TECHNOLOGY ASSESSMENT- A SYSTEMATIC REVIEW AND RESEARCH AGENDA

    Oct 1, 2018, 00:00

  • PCV104 - BETA-BLOCKERS, ANGIOTENSIN II, AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH HEART FAILURE. DIFFERENCES IN PRESCRIPTION BY GENDER, SOCIOECONOMIC STATUS AND COMORBIDITY AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE ...

    Oct 1, 2018, 00:00

  • PCN335 - TIME TRENDS IN FRONTLINE SYSTEMIC THERAPY UTILIZATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PIN79 - ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE- A REAL-WORLD-BASED ANALYSIS FROM PITER DATA

    Oct 1, 2018, 00:00

  • PMD152 - HEALTHCARE RESOURCE UTILIZATION, COMPLICATIONS AND COSTS FOR OPEN REDUCTION INTERNAL FIXATION OF THE FEMUR, TIBIA AND FIBULA

    Oct 1, 2018, 00:00

  • PHP79 - LESS HASTE, MORE SPEED? DO EUROPEAN ACCELERATED AUTHORISATIONS TRANSLATE INTO EARLY REIMBURSEMENT AND PATIENT ACCESS?

    Oct 1, 2018, 00:00

  • PRM88 - THE ADVANCEMENT OF TOOLS FOR AUTOMATING DATA EXTRACTION IN SYSTEMATIC REVIEWS

    Oct 1, 2018, 00:00

  • PSY92 - ECONOMIC AND PATIENT OUTCOMES OF GENERIC AND BRAND-NAME STATINS USED IN ROUTINE CLINICAL PRACTICE IN SPAIN

    Oct 1, 2018, 00:00

  • PCN149 - COST-EFFECTIVENESS OF BRCA1/2 MUTATION PROFILING TO TARGET OLAPARIB USE IN PATIENTS WITH METASTATIC BREAST CANCER IN JAPAN

    Oct 1, 2018, 00:00

  • PSY201 - A SYSTEMATIC REVIEW OF DISCRETE CHOICE EXPERIMENTS IN HEMOPHILIA

    Oct 1, 2018, 00:00

  • PMD153 - TURKISH PUBLIC PROCUREMENT SYSTEM FOR MEDICAL DEVICES- IS THERE ROOM FOR IMPROVEMENT WHEN VALUING QUALITY?

    Oct 1, 2018, 00:00

  • PCV15 - DRUGS FOR TREATING SEVERE HYPERTENSION IN PREGNANCY- A NETWORK META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS OF RANDOMIZED CLINICAL TRIALS

    Oct 1, 2018, 00:00

  • PMS84 - COMPARISON OF HTA ASSESSMENTS OF SARILUMAB IN DIFFERENT SUBPOPULATIONS FOR RHEUMATOID ARTHRITIS

    Oct 1, 2018, 00:00

  • PRS70 - REAL-LIFE RETROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE AND ECONOMIC BURDEN OF SEVERE ASTHMA

    Oct 1, 2018, 00:00

  • PND42 - BURDEN OF MULTIPLE SCLEROSIS IN RUSSIA AND EUROPE

    Oct 1, 2018, 00:00

  • PUK30 - THE BURDEN ASSOCIATED WITH COMPLEMENT 3 GLOMERULOPATHY (C3G)

    Oct 1, 2018, 00:00

  • PIN47 - THE POTENTIAL ROLE OF COST-EFFECTIVENESS ANALYSIS AND INCREMENTAL COST-EFFECTIVENESS RATIO THRESHOLDS IN THE UNITED STATES CENTERS FOR DISEASE CONTROL AND PREVENTION’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (CDC ACIP) VACCINAT ...

    Oct 1, 2018, 00:00

  • PHP32 - IMPACT OF MANUFACTURER COMPETITION ON PRESCRIPTION DRUG PRICE INFLATION IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PHP94 - DOES THE ORPHAN DESIGNATION INCREASE THE CHANCES OF POSITIVE HTA OPINION IN FRANCE, GERMANY AND UK?

    Oct 1, 2018, 00:00

  • PRM158 - PREDICTIVE BIOMARKERS OF TREATMENT SUCCESS IN ADVANCED NON–SMALL CELL LUNG CANCER PATIENTS USING MULTIVARIATE CAUSAL INFERENCE.

    Oct 1, 2018, 00:00

  • PHP121 - DISCRIMINATION IN ACCESS TO SCHEDULED SURGERY IN THE PORTUGUESE NHS- A SURVIVAL MODEL ANALYSIS

    Oct 1, 2018, 00:00

  • PCN181 - COST-UTILITY ANALYSIS OF ADJUVANT PERTUZUMAB-BASED REGIMEN IN WOMEN WITH HER2-POSITIVE BREAST CANCER IN ITALY

    Oct 1, 2018, 00:00

  • PIN22 - A PAYER PERSPECTIVE OF THE HOSPITAL INPATIENT ADDITIONAL CARE COSTS OF ANTIMICROBIAL RESISTANCE IN FRANCE- A MATCHED CASE-CONTROL STUDY

    Oct 1, 2018, 00:00

  • PMD75 - THE COST-EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION- EXPLORING THE ITALIAN NATIONAL HEALTH SYSTEM PERSPECTIVE AND CONSIDERING DIFFERENT PATIENTS RISK GROUPS

    Oct 1, 2018, 00:00

  • PRS69 - IMPACT OF THE INTERNATIONAL REFERENCE PRICING ON ACCESS TO STANDARD THERAPY DRUGS FOR COPD

    Oct 1, 2018, 00:00

  • PHP222 - IDENTIFYING THE KEY DRIVERS AFFECTING THE REIMBURSEMENT OF THERAPEUTIC VACCINES IN EU5 COUNTRIES USING A WEB-BASED PORTAL TO ENGAGE PAYERS

    Oct 1, 2018, 00:00

  • PRM223 - THE MISSING DATA PROBLEM- USING PROPENSITY SCORES TO ESTIMATE NON-RANDOMISED TREATMENT EFFECTS WITH MISSING COVARIATE DATA

    Oct 1, 2018, 00:00

  • PRM107 - CAN ACCOUNTING FOR MISSING DATA CAST DOUBT ON PREVIOUS CONCLUSIONS REEVALUATING A 10 YEAR COST-EFFECTIVENESS ANALYSIS (CEA) OF THE DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPP/DPPOS)?

    Oct 1, 2018, 00:00

  • PCN302 - IS THE NEW NICE APPRAISAL PROCESS FOR ONCOLOGY INDICATIONS TOO POSITIVE IN ITS ASSESSMENT OF CANCER DRUGS IN ENGLAND?

    Oct 1, 2018, 00:00

  • PMU11 - THE EFFECT OF FREQUENT FAMILY MEALTIMES ON CHILDREN AND ADOLESCENTS- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PSY147 - AVAILABILITY AND REIMBURSEMENT OF ORPHAN DRUGS IN THE CZECH REPUBLIC

    Oct 1, 2018, 00:00

  • PRM243 - NETWORK META-ANALYSES ON SURVIVAL DATA- A COMPARISON AND GUIDANCE FOR DIFFERENT METHODOLOGIES

    Oct 1, 2018, 00:00

  • PSS23 - SWITCH PATTERNS AND TOTAL COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIASIS

    Oct 1, 2018, 00:00

  • PRM46 - MEASURING AND ANALYSING THE MATURITY OF OVERALL SURVIVAL DATA FOR TREATMENTS FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA

    Oct 1, 2018, 00:00

  • PND147 - WALKING DISORDERS IN MS- HOW DO THEY IMPACT PATIENTS’ QUALITY OF LIFE? RESULTS FROM AN OBSERVATIONAL STUDY CONDUCTED VIA AN ONLINE PATIENT COMMUNITY

    Oct 1, 2018, 00:00

  • PIN63 - A COST-MINIMIZATION MODEL TO EVALUATE THE IMPACT OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMPLICATED SKIN AND SOFT TISSUE INFECTIONS IN HOSPITALIZED ADULTS IN SPAIN

    Oct 1, 2018, 00:00

  • PIN106 - GETTING CLOSER TO THE GOAL- MEASUREMENT OF THE 90 90 90 TARGETS TO END THE AIDS EPIDEMIC IN THE COLOMBIAN HEALTH SYSTEM

    Oct 1, 2018, 00:00

  • PND136 - FUNCTIONAL, EMOTIONAL AND SOCIAL IMPACT OF MIGRAINE IN PORTUGAL

    Oct 1, 2018, 00:00

  • PDB117 - CHANGES IN PATIENT REPORTED OUTCOMES, ATTITUDES AND HEALTH BEHAVIORS IN 606 PEOPLE WITH DIABETES FOLLOWING 2 MONTHS USE OF THE DRUGSTARS HEALTH APP

    Oct 1, 2018, 00:00

  • PND80 - AN OBSERVATIONAL STUDY OF IVACAFTOR IN PATIENTS WITH CYSTIC FIBROSIS IN FRANCE- FIRST INTERIM ANALYSIS OF HEALTH CARE RESOURCE UTILIZATION FROM THE BRIO STUDY

    Oct 1, 2018, 00:00

  • PIN102 - IMPACT OF DEPRESSION AND ITS ASSOCIATION TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY ADHERENCE AND ADVERSE DRUG REACTIONS IN PEOPLE LIVING WITH HIV IN INDIA

    Oct 1, 2018, 00:00

  • PMU66 - COST-EFFECTIVENESS ANALYSIS OF IXEKIZUMAB VERSUS SECUKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS AND CONCOMITANT MODERATE-TO-SEVERE PSORIASIS IN SPAIN

    Oct 1, 2018, 00:00

  • PCV26 - LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A VERY HIGH CARDIOVASCULAR RISK COHORT OF PATIENTS MANAGED BY GENERAL PRACTITIONERS IN ITALY

    Oct 1, 2018, 00:00

  • PIN109 - EVALUATION OF KNOWLEDGE, ATTITUDE AND PRACTICE REGARDING HIV/AIDS AMONG PREGNANT WOMEN AND THEIR PARTNERS INVOLVED IN PREVENTION MOTHER-TO-CHILD TRANSMISSION (PMTCT) PROGRAMS IN MALAWI.

    Oct 1, 2018, 00:00

  • PMS40 - COST – EFFECTIVENESS STUDY OF ETANERCEPT AS FIRST LINE TREATMENT FOR ANKYLOSING SPONDYLITIS IN COLOMBIA

    Oct 1, 2018, 00:00

  • PCP36 - IMPROVING THE QUALITY OF MEDICAL CARE IN HYPERTENSIVE DISORDERS DURING PREGNANCY

    Oct 1, 2018, 00:00

  • PCP35 - A MODERN MEDICAL KNOWLEDGE IN MANAGEMENT OF PATIENTS WITH INFLUENZA IN UKRAINE

    Oct 1, 2018, 00:00

  • PRM210 - METHODS USED TO IDENTIFY PATIENT REPORTED OUTCOME MEASURES IN VASCULAR DISEASES

    Oct 1, 2018, 00:00

  • PHP87 - COULD THE FRENCH COHORT ATU PROGRAM BE THE MODEL EUROPE NEEDS TO HARMONIZE COMPASSIONATE USE PROGRAMS?

    Oct 1, 2018, 00:00

  • PCN339 - SPEAR-BLADDER (STUDY INFORMING TREATMENT PATHWAY DECISION IN BLADDER CANCER)- TIMING OF TREATMENT FOLLOWING FIRST-LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED AND METASTATIC UROTHELIAL CANCER IN THE COMMUNITY ONCOLOGY SETTING IN ...

    Oct 1, 2018, 00:00

  • PCN334 - OUTCOMES OF PERIPHERAL T-CELL LYMPHOMA (PTCL) PATIENTS TREATED IN THE REAL WORLD

    Oct 1, 2018, 00:00

  • PRM83 - COMPARATIVE ASSSESMENT OF ORAL ANTIDIABETIC DRUG-MEDIATED GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BETWEEN TWO DIFFERENT REAL-WORLD DATABASES

    Oct 1, 2018, 00:00

  • PCN314 - HEALTH-TECHNOLOGY ASSESSMENTS IN ONCOLOGY- RESULTS OF A REVIEW OF DECISIONS IN GERMANY

    Oct 1, 2018, 00:00

  • PMU81 - PHYSICIANS' PREFERENCES WITH RESPECT TO ADHERENCE PROGRAMS- A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2018, 00:00

  • PMS94 - AVAILABILITY OF TOOLS TO ASSESS PROMS IN HIP ARTHROPLASTY IN SPAIN. A SYSTEMATIC REVIEW.

    Oct 1, 2018, 00:00

  • PMU85 - CONSUMER SURVEY OF HEALTH AND RECREATIONAL TOURISM IN THE WEST-TRANSDANUBIAN REGION OF HUNGARY

    Oct 1, 2018, 00:00

  • PRM275 - FIELD RESEARCH FOR THE DETERMINATION OF THE INDIRECT COSTS OF PERITONEAL DIALYSIS AND HEMODIALYSIS IN TURKEY

    Oct 1, 2018, 00:00

  • PRM192 - TYPE 2 DIABETES MELLITUS- LACK OF GOOD PRACTICES FOR REAL-WORLD EVIDENCE STUDIES.

    Oct 1, 2018, 00:00

  • PMU23 - ANALYSIS OF PATIENT SAFETY INCIDENTS REPORTS AT A UNIVERSITARY HOSPITAL

    Oct 1, 2018, 00:00

  • PHP207 - ASSESSMENT OF PHARMACIST MEDICATION CONSULTATION IN COMMUNITY PHARMACIES LOCATED IN TEHRAN

    Oct 1, 2018, 00:00

  • PHP348 - REGENERATIVE MEDICINE ADVANCED THERAPY- A BUDGET IMPACT ANALYSIS

    Oct 1, 2018, 00:00

  • PCN174 - NEPA, AN ORAL FIXED COMBINATION OF NETUPITANT AND PALONOSETRON, IS A COST-EFFECTIVE INTERVENTION FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN GERMANY AND GREECE

    Oct 1, 2018, 00:00

  • PSY59 - ORPHAN DRUGS PRICES COMPARISON IN MIDDLE EAST NORTH AFRICA (MENA) REGION

    Oct 1, 2018, 00:00

  • PRM162 - A PIECEWISE APPROACH TO THE EXTRAPOLATION OF INVASIVE DISEASE-FREE SURVIVAL (IDFS) IN THE ADJUVANT TREATMENT OF HER2+ BREAST CANCER

    Oct 1, 2018, 00:00

  • PND114 - IMPACT OF A PHARMACIST-LED COMMUNITY INTERVENTIONAL PROGRAM TO PREVENT COGNITIVE DETERIORATION IN COMMUNITY-DWELLING HONG KONG ELDERS WITH HIGH ANTICHOLINERGIC COGNITIVE BURDEN

    Oct 1, 2018, 00:00

  • PRM168 - FLUFFY, SOFT OR HARD LIKE NUTS; PASSING POO EASILY AROUND THE WORLD - CHALLENGES IN TRANSLATING THE CROHN’S DISEASE QUESTIONNAIRE INTO 80 LANGUAGES

    Oct 1, 2018, 00:00

  • PCP25 - ARTIFICIAL INTELLIGENCE ASSISTED LITERATURE REVIEWS- KEY CONSIDERATIONS FOR IMPLMENTATION IN HEALTH CARE RESEARCH

    Oct 1, 2018, 00:00

  • PRM104 - EVALUATION OF DATA COLLECTION DURATION IN RETROSPECTIVE NONINTERVENTIONAL MEDICAL RECORD REVIEW ONCOLOGY STUDIES CONDUCTED IN THE UNITED STATES (US), CANADA, UNITED KINGDOM (UK), GERMANY, FRANCE AND SPAIN

    Oct 1, 2018, 00:00

  • PHP41 - IMPACT OF PRICE REGULATION ORDINANCE ON TOP 20 PRESCRIBED MEDICINES PRICES IN BOSNIA AND HERZEGOVINA

    Oct 1, 2018, 00:00

  • PHP217 - TIME TO MARKET AND PRICE COMPARISON FOR BIOSIMILAR DRUGS IN EU5

    Oct 1, 2018, 00:00

  • PHP69 - A REVIEW OF FUNDING PATHS FOR E-HEALTH SOLUTIONS IN THE EU5, US AND CANADA

    Oct 1, 2018, 00:00

  • PHP301 - THE TIME IS NOW FOR EUROPEAN HTA- HOW WILL THE EVOLUTION OF EUROPEAN HTA IMPACT ACCESS TO INNOVATIVE MEDICINES?

    Oct 1, 2018, 00:00

  • HT3 - DESCRIPTION AND COMPARISON OF EUROPEAN CROSS-BORDER INITIATIVES ON DRUG PROCUREMENT

    Oct 1, 2018, 00:00

  • PRM131 - HEPATITIS C VIRUS ELIMINATION AND ERADICATION MODELS- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSY44 - TOCILIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE TREATMENT OF GIANT CELL ARTERITIS- A BUDGET IMPACT ANALYSIS IN ITALY

    Oct 1, 2018, 00:00

  • PMH48 - PHARMACOECONOMIC STUDY OF THE EFFECTIVENESS AND SAFETY OF ANTIPSYCHOTICS

    Oct 1, 2018, 00:00

  • PSY132 - ECONOMIC CRISIS AND THE EFFECT ON PHARMACOECONOMICS IN A REGIONAL GENERAL HOSPITAL

    Oct 1, 2018, 00:00

  • PRM164 - THREE STATE MARKOV MODEL INVESTIGATING THE PROGRESSION OF BREAST CANCER

    Oct 1, 2018, 00:00

  • Copyright/Subscription

    Oct 1, 2018, 00:00

  • PCN104 - ECONOMIC ANALYSIS OF COSTS AND RESOURCE CONSUMPTION OF IXAZOMIB IN PATIENTS WITH RELAPSED / REFRACTORY MULTIPLE MYELOMA IN AUSTRIA

    Oct 1, 2018, 00:00

  • PRM101 - THE COST BURDEN OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN RUSSIAN FEDERATION

    Oct 1, 2018, 00:00

  • PMU120 - ASSESSING THE RISK FACTORS OF COMPLICATIONS RELATED TO PERIPHERAL INTRAVENOUS CANNULAS

    Oct 1, 2018, 00:00

  • PDB70 - ECONOMIC EVALUATION OF THE USE OF RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR (HEBERPROT-P®) AS AN ADJUVANT OF CONVENTIONAL THERAPY FOR THE TREATMENT OF DIABETIC FOOT ULCER

    Oct 1, 2018, 00:00

  • PHP299 - THREE YEARS OF SINATS

    Oct 1, 2018, 00:00

  • PDB13 - SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS OF SGLT-2 INHIBITORS AND METFORMIN AS ADD-ON TO INSULIN FOR THE TREATMENT OF TYPE 1 DIABETES

    Oct 1, 2018, 00:00

  • HT6 - DO SPAIN AND PORTUGAL EVALUATORS AND DECISION MAKERS GIVE THE SAME IMPORTANCE TO EVALUATION CRITERIA OF INNOVATIVE MEDICINES?

    Oct 1, 2018, 00:00

  • PSY130 - THE RELATIONSHIP BETWEEN DISEASE TYPE AND CONDITIONAL OR EXCEPTIONAL APPROVAL BY EMA FOR ORPHAN DRUGS IN 2017

    Oct 1, 2018, 00:00

  • PMS105 - EXAMINATION OF CORE TRAINING PROGRAM ON THE CHANGE OF LOW BACK PAIN, MUSCLE STRENGTH AND LUMBAR MOTOR CONTROLL AMONG PROFESSIONAL FIREFIGHTERS

    Oct 1, 2018, 00:00

  • PMD171 - HEALTH TECHNOLOGY ASSESSMENT OF COMPANION DIAGNOSTICS ALONGSIDE THERAPEUTC AGENTS IN ONCOLOGY- EXPERIENCE OF THE NICE TECHNOLOGY APPRAISAL PROGRAMME

    Oct 1, 2018, 00:00

  • PDB90 - ASSOCIATION BETWEEN SULFONYLUREA (SU) TREATMENT AND TRAFFIC ACCIDENTS IN DENMARK

    Oct 1, 2018, 00:00

  • PRS73 - THE BUDGET IMPACT OF NICOTINIC SUBSTITUTE REIMBURSEMENT

    Oct 1, 2018, 00:00

  • PHP151 - THE PERCEPTION OF THE PUBLIC ABOUT DISABILITY AND THE MEDICAL AND SOCIAL MODEL OF DISABILITY- A LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCN348 - QUALITY OF LIFE IN END-STAGE CANCER DISEASE

    Oct 1, 2018, 00:00

  • PCV56 - CLINICAL AND ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE AND VALUE OF EVOLOCUMAB TREATMENT IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN SWEDEN

    Oct 1, 2018, 00:00

  • PCV79 - REAL-WORLD COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH VITAMIN K ANTAGONISTS IN THE CONTEXT OF STROKE PREVENTION IN ATRIAL FIBRILLATION IN FRANCE

    Oct 1, 2018, 00:00

  • PRM14 - USING EXPERT ELICITATION TO CAPTURE COST-EFFECTIVENESS MODEL UNCERTAINTIES- VALUING EXPERTS' CONTRIBUTION

    Oct 1, 2018, 00:00

  • PSY87 - ECONOMIC BURDEN OF TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY

    Oct 1, 2018, 00:00

  • PMU33 - ESTIMATING THE COST OF A CAESAREAN SECTION IN A PUBLIC HOSPITAL IN CYPRUS

    Oct 1, 2018, 00:00

  • PCN307 - APPLYING MULTI-CRITERIA DECISION ANALYSIS (MCDA) AS AN EVIDENCE BASED HEALTH TECHNOLOGY ASSESSMENT IN HEALTH CARE DECISION MAKING IN EGYPT

    Oct 1, 2018, 00:00

  • PSY172 - REAL WORLD EVIDENCE OF HEREDITARY HYPOPHOSPHATEMIA IN GERMANY – ANALYSIS OF GERMAN SHI CLAIMS DATA FOR PEDIATRIC PATIENTS

    Oct 1, 2018, 00:00

  • PHP260 - A EUROPEAN ANALYSIS OF FIXED DOSE COMBINATIONS PRICE SETTING

    Oct 1, 2018, 00:00

  • PRS89 - MEASUREMENT OF MAINTENANCE AND RELIEVER USE IN ASTHMA- A SYSTEMATIC REVIEW OF THE LITERATURE

    Oct 1, 2018, 00:00

  • PCN235 - COMBINATION ONCOLOGY THERAPIES IN THE EU5- NAVIGATING THE ROAD TO REIMBURSEMENT AND OPTIMIZING UPTAKE IN MALIGNANT MELANOMA

    Oct 1, 2018, 00:00

  • PRS88 - COMPARABILITY OF A PROVISIONED DEVICE VERSUS BRING YOUR OWN DEVICE FOR COMPLETION OF PATIENT-REPORTED OUTCOME (PRO) MEASURES BY PARTICIPANTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)- QUANTITATIVE STUDY FINDINGS

    Oct 1, 2018, 00:00

  • PSS11 - PATIENTS UNDER ATOPIC DERMATITIS TREATMENT IN PORTUGAL- RESULTS FROM A PHYSICIANS’ SURVEY

    Oct 1, 2018, 00:00

  • PHP171 - REVISITING REIMBURSED DRUGS WITH ALTERNATIVE PAYMENT MODEL IN TURKEY- 2016-2018

    Oct 1, 2018, 00:00

  • PSS73 - IMPACT OF CENEGERMIN ON THE QUALITY OF LIFE IN NEUROTROPHIC KERATOPATHY

    Oct 1, 2018, 00:00

  • PRM34 - FRENCH EFFICIENCY OPINIONS OF THE ECONOMIC AND PUBLIC HEALTH COMMITTEE (CEESP)- IS THERE AN IMPACT ON THE MARKET ACCESS FOR INNOVATIVE DRUGS?

    Oct 1, 2018, 00:00

  • PCN80 - BUDGET IMPACT ANALYSIS WITH USE OF SUBCUTANEUS TRASTUZUMAB

    Oct 1, 2018, 00:00

  • PSS65 - DEVELOPMENT OF THE NEUROTROPHIC KERATOPATHY QUESTIONNAIRE- QUALITATIVE RESEARCH

    Oct 1, 2018, 00:00

  • PIN19 - A COST COMPARISON OF TREATING CHRONIC HEPATITIS C PATIENTS WITH SOFOSBUVIR-BASED REGIMENS

    Oct 1, 2018, 00:00

  • PSS3 - A SYSTEMATIC REVIEW AND META-ANALYSIS OF REAL-WORLD EVIDENCE STUDIES OF INTRAVITREAL AFLIBERCEPT IN WET AGE-RELATED MACULAR DEGENERATION

    Oct 1, 2018, 00:00

  • PND46 - ECONOMIC BURDEN OF FRAGILE X SYNDROME IN EUROPE AND THE US- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCN34 - PEMBROLIZUMAB PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NSCLC – A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PHP76 - ANALYSIS OF APPROVAL TIMING FOR 89 NEW DRUGS IN ITALY FROM JANUARY 2015 TO MAY 2018

    Oct 1, 2018, 00:00

  • PMD74 - HIGH RESOLUTION MELTING FOR THE SCREENING OF RESISTANCE-ASSOCIATED MUTATIONS IN MYCOBACTERIUM LEPRAE IN LEPROSY PATIENTS WITH SUSPECTED RELAPSE ASSOCIATED WITH RESISTANCE.

    Oct 1, 2018, 00:00

  • PCN207 - NEW DRG-BASED REIMBURSEMENT OF ANTINEOPLASTIC PHARMACOTHERAPY AT RUSSIAN HOSPITALS

    Oct 1, 2018, 00:00

  • PRM126 - A COMPARISON OF MIXTURE CURE AND STANDARD PARAMETRIC MODELING TO ESTIMATE LONG-TERM SURVIVAL FOR SMALL-CELL LUNG CANCER IN PATIENTS TREATED WITH NIVOLUMAB AFTER PROGRESSION

    Oct 1, 2018, 00:00

  • PCN70 - ASSESSING THE BUDGET IMPACT OF INCLUDING SUNITINIB FOR THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN ARGENTINA

    Oct 1, 2018, 00:00

  • PND81 - HEALTH SERVICE USE IN HIGH AND LOW SEVERITY DRAVET SYNDROME IN THE EU5

    Oct 1, 2018, 00:00

  • PCN162 - DENOSUMAB VERSUS BISPHOSPHONATES FOR THE TREATMENT OF BONE METASTASES FROM SOLID TUMORS- A SYSTEMATIC REVIEW OF ECONOMIC STUDIES

    Oct 1, 2018, 00:00

  • PIN20 - A COST-EFFECTIVENESS ANALYSIS OF THE INFLUENZA VACCINE IN ADULT PATIENTS WITH CANCER

    Oct 1, 2018, 00:00

  • PCN96 - INITIAL THERAPY FOR ADVANCED PROSTATE CARCINOMA (PCA) WITH A GNRH AGONIST (GNRHA) AND ANTAGONISTS - A RETROSPECTIVE ANALYSIS OF PRESCRIPTION PATTERNS AND HOSPITAL COSTS BASED ON GERMAN GKV [GESETZLICHE KRANKENVERSICHERUNG (STATUTORY ...

    Oct 1, 2018, 00:00

  • PHP129 - CHALLENGES AND OPPORTUNITIES IN THE BIOLOGICALS-BIOSIMILARS MARKET- SUSTAINABILITY AND MARKET DIFFERENTIATION

    Oct 1, 2018, 00:00

  • PCN178 - COST-EFFECTIVENESS OF PEMBROLIZUMAB AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED UROTHELIAL CANCER IN FRANCE

    Oct 1, 2018, 00:00

  • PHP209 - FUNDING OF CLINICAL TRIALS IN UNIVERSITY HOSPITAL ENVIRONMENT

    Oct 1, 2018, 00:00

  • PMS62 - COST-EFFECTIVENESS OF REDUCING ARTHRITIS FATIGUE BY CLINICAL TEAMS (RAFT) USING COGNITIVE–BEHAVIOURAL APPROACHES- A RANDOMISED CONTROLLED TRIAL

    Oct 1, 2018, 00:00

  • PSY21 - DELETERIOUS EFFECT OF BLOOD TRANSFUSIONS IN A COHORT OF ANAEMIC INPATIENTS

    Oct 1, 2018, 00:00

  • PSY137 - ORPHAN DRUG ACCESS AND REIMBURSEMENT IN THE EU5- CYSTIC FIBROSIS AND DUCHENNE MUSCULAR DYSTROPHY

    Oct 1, 2018, 00:00

  • PRS72 - A COST ESTIMATION OF MANAGEMENT OF ALLERGIC ASTHMA IN ITALY

    Oct 1, 2018, 00:00

  • PCV16 - A SYSTEMATIC REVIEW ON THE EFFICACY OF PHARMACOLOGICAL TREATMENTS IN PATIENTS WITH HEART FAILURE (HF) WITH PRESERVED EJECTION FRACTION (HFPEF)

    Oct 1, 2018, 00:00

  • PCN144 - COST-EFFECTIVENESS OF CABOZANTINIB FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF PRIOR THERAPY IN SOUTH KOREA

    Oct 1, 2018, 00:00

  • PND79 - REDUCED HEALTHCARE RESOURCE UTILISATION FOR PATIENTS TREATED WITH DELAYED RELEASE DIMETHYL FUMARATE VS INJECTABLE THERAPIES- FINDINGS FROM A REAL-WORLD CROSS-SECTIONAL STUDY OF MS PATIENTS

    Oct 1, 2018, 00:00

  • PCN98 - PALLIATIVE TREATMENT AND ITS COST IN THE LAST SIX MONTHS OF LIFE FOR METASTATIC COLORECTAL CANCER PATIENTS

    Oct 1, 2018, 00:00

  • PMS2 - RETROSPECTIVE STUDY TO EVALUATE OSTEOARTHRITIS POPULATION IN GERMANY AND IDENTIFY INFLUENTIAL FACTORS IN FAST, MEDIUM AND SLOW PROGRESSING PATIENTS

    Oct 1, 2018, 00:00

  • PHP280 - IS THERE A REASON TO ARGUE FOR HIGHER DECISION-MAKING EFFICIENCY WITH SINATS?

    Oct 1, 2018, 00:00

  • PHP101 - SOCIO-ECONOMIC AND SOCIO-DEMOGRAPHIC DRIVERS INFLUENCING PREVALENCE OF ANTIBIOTIC USE- AN ANALYSIS IN SOUTHERN ITALY SETTING

    Oct 1, 2018, 00:00

  • Vaccination Programs- Economic and Leadership Considerations

    Oct 1, 2018, 00:00

  • PRM134 - USING ADJUSTED INDIRECT COMPARISON IN HTA TO OVERCOME SHORT FOLLOW-UP TIME IN REGULATORY RANDOMIZED CONTROLED CLINICAL TRIALS- RIBOCICLIB AS FIRST-LINE THERAPY FOR HR-POSITIVE, ADVANCED BREAST CANCER

    Oct 1, 2018, 00:00

  • PRS35 - THE ECONOMIC IMPACT AND VARIABILITY OF MANAGING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN THE UK HEALTHCARE SETTING

    Oct 1, 2018, 00:00

  • PRS25 - A RETROSPECTIVE DATABASE STUDY TO DEFINE A PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENT COHORT AND EVALUATE THE ECONOMIC BURDEN OF ILLNESS IN FRANCE

    Oct 1, 2018, 00:00

  • PHP356 - COMPARATIVE ANALYSIS BETWEEN OLD AND NEW ITALIAN INNOVATION RATING SYSTEM

    Oct 1, 2018, 00:00

  • PSS20 - ECONOMIC BURDEN OF PSORIASIS (PSO) IN TURKEY

    Oct 1, 2018, 00:00

  • PRS96 - PATIENT PERCEIVED IMPACT OF NURSE-LED SELF-MANAGEMENT INTERVENTIONS FOR COPD- A SYSTEMATIC REVIEW OF QUALITATIVE RESEARCH

    Oct 1, 2018, 00:00

  • PHP340 - UNDERSTANDING PHYSICIANS’ CONCEPTION OF QUALITY OF HEALTH CARE DELIVERY- AN EXPLORATIVE STUDY USING THE REPERTORY GRID TECHNIQUE

    Oct 1, 2018, 00:00

  • PRM74 - CLINICAL OUTCOME ASSESSMENTS IN DRUG APPROVALS- A REVIEW OF LABEL CLAIMS IN THE UNITED STATES AND EUROPE (2013-2017)

    Oct 1, 2018, 00:00

  • PCN141 - COST-EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA IN GREECE

    Oct 1, 2018, 00:00

  • PSY43 - BUDGET IMPACT ANALYSIS OF METHOXYFLURANE (PENTHROX®) FOR EMERGENCY RELIEF OF MODERATE-TO-SEVERE TRAUMA PAIN IN THE SWEDISH SETTING

    Oct 1, 2018, 00:00

  • PSY78 - THE ECONOMIC AND HEALTHCARE BURDEN OF ANCA-ASSOCIATED VASCULITIS (AAV) IN GERMANY

    Oct 1, 2018, 00:00

  • PSY163 - IDENTIFICATION OF KEY ORPHAN DRUG ATTRIBUTES IN PREDICTING THE EXPECTED LEVEL OF PAYER MANAGEMENT IN THE US AND EU3

    Oct 1, 2018, 00:00

  • RM4 - EXPLORING TIME-DEPENDENT VARIATION OF PATIENT-REPORTED OUTCOME SCORES ACROSS DIFFERENT TIME-POINTS FOR PATIENTS WITH MULTIPLE CONDITIONS- A MIXED METHODS LONGITUDINAL STUDY

    Oct 1, 2018, 00:00

  • PND150 - IMPACT OF INOTERSEN ON CONDITION-SPECIFIC QUALITY OF LIFE (QOL) FOR PATIENTS WITH HATTR AMYLOIDOSIS- RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

    Oct 1, 2018, 00:00

  • PRM122 - BOOTSTRAPPING PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL TO CAPTURE THEIR CORRELATION IN PROBABILISTIC SENSITIVITY ANALYSES

    Oct 1, 2018, 00:00

  • PIN48 - COST-EFFECTIVENESS ANALYSIS OF ANIDULAFUNGIN FOR THE MANAGEMENT OF INVASIVE CANDIDIASIS IN COLOMBIAN ADULTS

    Oct 1, 2018, 00:00

  • PHP1 - EXPECTED DEMAND FOR HEALTH SERVICES FROM A VOLUNTARY INSURER

    Oct 1, 2018, 00:00

  • PSY18 - RAPID IMPROVEMENTS IN MOTOR FUNCTION IN SPINAL MUSCULAR ATROPHY TYPE 1 FOLLOWING AVXS-101 GENE REPLACEMENT THERAPY

    Oct 1, 2018, 00:00

  • PND152 - IMPACT OF INOTERSEN ON GENERIC HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS WITH HATTR AMYLOIDOSIS- RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

    Oct 1, 2018, 00:00

  • PCN265 - END OF LIFE CANCER CHEMOTHERAPY- A RETROSPECTIVE STUDY DURING INTENSIVE CARE UNIT (ICU) STAY

    Oct 1, 2018, 00:00

  • PGI51 - PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) REPORT HIGHER ECONOMIC BURDEN THAN CONTROLS- RESULTS FROM THE EU5 NATIONAL HEALTH AND WELLNESS SURVEY

    Oct 1, 2018, 00:00

  • PMD149 - CLAVICLE FRACTURE- TREATMENT, COMPLICATIONS, AND COST IN THE COMMERCIALLY-INSURED POPULATION

    Oct 1, 2018, 00:00

  • PRM25 - INCORPORATING EXPERT OPINION TO IMPROVE ESTIMATES OF LONG-TERM SURVIVAL WHEN FOLLOW-UP OF EMPIRICAL STUDIES IS SHORT

    Oct 1, 2018, 00:00

  • PGI42 - NON-PERSISTENCE WITH IMMUNOSUPPRESANT, ANTI-TUMOR NECROSIS FACTOR, AND ANTI-INTEGRIN AGENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE- A RETROSPECTIVE CLAIMS DATA ANALYSIS IN GERMANY

    Oct 1, 2018, 00:00

  • PMH54 - PATTERNS OF LONG-TERM CUSTODIAL CARE IN PARKINSON DISEASE PSYCHOSIS

    Oct 1, 2018, 00:00

  • PSS58 - TREATMENT PATTERNS FOR AGE-RELATED MACULAR DEGENERATION IN SPAIN- KEYS FOR IMPROVING MANAGEMENT IN DAILY CLINICAL PRACTICE

    Oct 1, 2018, 00:00

  • PND124 - HUMANISTIC AND ECONOMIC BURDEN OF PROGRESSIVE SUPRANUCLEAR PALSY- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PRM252 - SIMULATED TREATMENT COMPARISON- IMPLICATIONS AND CHALLENGES OF AN ALTERNATIVE APPROACH TO ESTIMATING THE RELATIVE EFFICACY OF NIVOLUMAB VERSUS RELEVANT COMPARATOR CHEMOTHERAPY TREATMENTS FOR ADVANCED/METASTATIC UROTHELIAL CARCINOMA ...

    Oct 1, 2018, 00:00

  • PSS7 - QUALITY OF LIFE IMPROVEMENTS IN PSORIASIS WITH SECUKINUMAB IN A DIFFICULT TO TREAT POPULATION OF ANTI-TNF ALPHA FAILURE PATIENTS FROM THE UK AND REPUBLIC OF IRELAND

    Oct 1, 2018, 00:00

  • PDB8 - FACTORS ASSOCIATED WITH UNCONTROLLED GLYCEMIA AMONG OUTPATIENTS WITH TYPE 2 DIABETES

    Oct 1, 2018, 00:00

  • PCV65 - EXPERT ANALYSIS ON COST ANALYSIS OF MANAGEMENT OF CARDIOVASCULAR DISEASE CO-MORBIDITIES

    Oct 1, 2018, 00:00

  • PMU16 - DISPENSING PATTERNS OF VACCINES IN A PRIVATE HEALTHCARE SETTING IN SOUTH AFRICA

    Oct 1, 2018, 00:00

  • PRM18 - REAL-WORLD DATA (RWD) COLLECTION ALONGSIDE EARLY ACCESS TO MEDICINES SCHEMES (EAMS) - NIVOLUMAB IN GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA (GC/GEJ) AFTER TWO OR MORE PRIOR THERAPIES

    Oct 1, 2018, 00:00

  • PIN32 - THE PUBLIC HEALTH AND ECONOMIC IMPACT OF INCREASED SCREENING AND IMMEDIATE INITIATION OF ANTIRETROVIRAL TREATMENT FOR HIV-1 IN THE UK

    Oct 1, 2018, 00:00

  • PND12 - NATALIZUMAB VERSUS GLATIRAMER ACETATE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS- A NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PMD139 - VALUE-BASED PROCUREMENT OF MEDICAL EQUIPMENT IN EUROPE – DID THE 2014 EU DIRECTIVE INFLUENCE TENDERING PRACTICES AND EVIDENCE DEMAND?

    Oct 1, 2018, 00:00

  • PCN258 - HEALTHCARE RESOURCE UTILISATION (HCRU) AMONG PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN- THE SCAN-LEAF STUDY

    Oct 1, 2018, 00:00

  • PMD144 - SELECTIVE HEALTH BENEFIT TO REDUCE ECONOMIC BURDEN OF PATIENTS- CASE OF CANCER SURGERY

    Oct 1, 2018, 00:00

  • PCV59 - HEALTH INSURANCE COST OF ESSENTIAL (PRIMARY) HYPERTENSION IN HUNGARY- A NATIONWIDE, REAL-WORLD COST OF ILLNESS STUDY

    Oct 1, 2018, 00:00

  • PCN168 - COST-EFFECTIVENESS OF SORAFENIB IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PDB47 - THE ASSOCIATION BETWEEN RENAL FUNCTION AND HEALTHCARE COSTS IN US PATIENTS WITH TYPE 2 DIABETES

    Oct 1, 2018, 00:00

  • PCN393 - THE BURDEN OF INFORMAL CARE FOR BREAST CANCER PATIENTS IN THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PMS106 - COMPARISON OF DYNAMIC AND STATIC BALANCE AMONG HUNGARIAN AND FINNISH ADOLESCENT FOOTBALL PLAYERS

    Oct 1, 2018, 00:00

  • Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination- A Systematic Review of the Literature

    Oct 1, 2018, 00:00

  • PCN311 - EUROPEAN MARKET ACCESS CHALLENGES FOR RELAPSED REFRACTORY MULTIPLE MYELOMA TRIPLET THERAPIES

    Oct 1, 2018, 00:00

  • PHP57 - EUROPEAN CONDITIONAL MARKETING AUTHORIZATION – DOES EARLY MARKETING AUTHORIZATION TRANSLATE INTO EARLY REIMBURSEMENT AND PATIENT ACCESS?

    Oct 1, 2018, 00:00

  • PHP67 - CURRENT INITIATIVES FUTURE OF E-HEALTH FUNDING PATHS

    Oct 1, 2018, 00:00

  • PDB57 - TRENDS IN USE OF DRUGS FOR DIABETES TREATMENT IN SLOVAKIA- REVIEW OF CONSUMPTION DATA FROM 2007 TILL 2017

    Oct 1, 2018, 00:00

  • PRS48 - COST – EFFECTIVENESS ANALYSIS OF VILANTEROL/FLUTICASONE FUROATE FOR ASTHMA TREATMENT IN THE RUSSIAN FEDERATION

    Oct 1, 2018, 00:00

  • PRM186 - MEASUREMENT PROPERTIES OF TRANSLATED VERSIONS OF MEASURES ASSESSING THE SUBJECTIVE EFFECTS OF TOBACCO- AND NICOTINE-CONTAINING PRODUCTS- A LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PSY176 - SIGNIFICANT BENEFIT AND RELATIVE EFFECTIVENESS ASSESSMENT OF ORPHAN MEDICINAL PRODUCTS IN THE EUROPEAN UNION- A COMPARATIVE ANALYSIS

    Oct 1, 2018, 00:00

  • PSS10 - QUANTITATIVE ANALYSIS OF DIABETIC RETINOPATHY (DR) IN THE UK USING ROUTINELY COLLECTED DATA FROM SCREENING PROGRAMME AND HOSPITAL EYE SERVICE (HES) DATABASES

    Oct 1, 2018, 00:00

  • PMS58 - ECONOMIC EVALUATION OF ANTERIOR APPROACH OF TOTAL HIP ARTHROPLASTY IN A TERTIARY HOSPITAL SETTINGS IN HUNGARY- A COST MINIMIZATION STUDY

    Oct 1, 2018, 00:00

  • PRM59 - DEVELOPING A MODELLING FRAMEWORK TO ASSESS THE COST-EFFECTIVENESS OF DIAGNOSTIC TESTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS

    Oct 1, 2018, 00:00

  • PMU79 - THE USE OF NETWORK META-ANALYSIS TO COMPARE DIFFERENT MEASURES OF MEDICATION ADHERENCE

    Oct 1, 2018, 00:00

  • PRM72 - PERFORMANCE OF AUTOMATED SCREENING OF CITATIONS COMPARED TO HUMAN REVIEWERS IN SYSTEMATIC LITERATURE REVIEWS- A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PCV66 - COSTS OF EARLY REHABILITATION AFTER STROKE IN CZECH CEREBROVASCULAR CENTERS

    Oct 1, 2018, 00:00

  • PRM10 - METHODOLOGICAL ASSESSMENT OF ECONOMIC ANALYSES ON COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS AND RELATED CLINICAL DECISION SUPPORT TOOLS IN INPATIENT CARE

    Oct 1, 2018, 00:00

  • PCV85 - COST-EFFECTIVENESS OF BETRIXABAN COMPARED WITH ENOXAPARIN OR FONDAPARINUX FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS IN HOSPITALISED ACUTE MEDICALLY ILL PATIENTS IN THE UNITED KINGDOM

    Oct 1, 2018, 00:00

  • PSY209 - PATIENT NEEDS, PERCEPTIONS AND ATTITUDINAL DRIVERS ASSOCIATED WITH OBESITY- A QUALITATIVE ONLINE BULLETIN BOARD STUDY

    Oct 1, 2018, 00:00

  • PCN250 - ASSESSING THE REAL WORLD USAGE OF PD-1 INHIBITORS IN ADVANCED MELANOMA ACROSS EU5

    Oct 1, 2018, 00:00

  • PRM236 - CALIBRATING MATCHING ADJUSTED INDIRECT COMPARISON ESTIMATE TO REAL-WORLD POPULATION

    Oct 1, 2018, 00:00

  • PND13 - REAL WORLD EVIDENCE (RWE) ON IMPACT OF AGE ON LONG-TERM PERSISTENCE TO DISEASE MODIFYING THERAPIES (DMTS) IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) IN AUSTRALIA

    Oct 1, 2018, 00:00

  • AD2 - A FULLY INTEGRATED CLINICAL TRIAL LIKE SYSTEM TO GUARANTEE PERSISTENCE ON PLANNED HEPATITIS C TREATMENT- EVIDENCE FROM THE REAL-WORLD

    Oct 1, 2018, 00:00

  • PHP283 - PHARMACEUTICAL CARE IN RESIDENTIAL SOCIO-HEALTH CENTERS- OPTIMISATION OF STORAGE AND DISPENSING CIRCUIT

    Oct 1, 2018, 00:00

  • PDB4 - THE EFFECT OF STATINS USAGE ON DIABETIC EYE COMPLICATIONS

    Oct 1, 2018, 00:00

  • PGI45 - RELIABILITY AND VALIDITY OF A NEW PATIENT-REPORTED OUTCOME FOR GASTROPARESIS

    Oct 1, 2018, 00:00

  • PHP65 - ANALYSIS OF ICER-ESTIMATED VALUE-BASED PRICES AND POTENTIAL DISCOUNTS FOR DRUGS IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PND56 - A COST-EFFECTIVENESS ANALYSIS USING REAL-WORLD DATA FROM THE MSBASE REGISTRY- COMPARING NATALIZUMAB TO FINGOLIMOD IN PATIENTS WITH INADEQUATE RESPONSE TO DISEASE-MODIFYING THERAPIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN ...

    Oct 1, 2018, 00:00

  • PRM62 - A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS BASED ON DECISION-ANALYTIC MODELING OF CANCER DRUGS

    Oct 1, 2018, 00:00

  • PHP195 - DO COMPANIES’ MARKET ACCESS TRAINING CAPABILITIES ADDRESS THE NEEDS OF TODAY’S COMPLEX PAYER MARKETPLACE?

    Oct 1, 2018, 00:00

  • PMU29 - EVALUATING BUDGET IMPACT ANALYSES FOR EXTRAMURAL DRUGS IN THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PGI12 - PREDICTORS OF READMISSION FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION USING THE FRENCH HEALTH INSURANCE DATABASE

    Oct 1, 2018, 00:00

  • PHP293 - ORPHAN DRUGS IN GERMANY - LESSONS LEARNED FROM AMNOG, BEST AND WORST PRACTICES AND STRATEGIC IMPLICATIONS

    Oct 1, 2018, 00:00

  • PHP365 - TRENDS AND CHARACTERISTICS OF MANAGED ACCESS AGREEMENTS APPROVED BY NICE

    Oct 1, 2018, 00:00

  • PHP14 - CO-CREATION OF PATIENT ENGAGEMENT QUALITY GUIDANCE AND QUALITY CRITERIA FOR MEDICINES DEVELOPMENT- AN INTERNATIONAL MULTI-STAKEHOLDER INITIATIVE

    Oct 1, 2018, 00:00

  • PDB9 - ASSOCIATION BETWEEN CLASS OF ANTIDIABETIC DRUGS AND INCIDENCE OF MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES MELITUS- A PROPORTIONAL HAZARD ANALYSIS USING DEEP LEARNING FOR RISK ADJUSTMENT

    Oct 1, 2018, 00:00

  • PCV157 - ASSOCIATION BETWEEN HEALTH-RELATED QUALITY OF LIFE AND ATRIAL FIBRILLATION SYMPTOM BURDEN- RESULTS OF A STUDY ON ATRIAL FIBRILLATION PATIENTS IN GERMANY, SWEDEN AND SWITZERLAND

    Oct 1, 2018, 00:00

  • PHP5 - DEVELOPMENT OF THE PATIENT ORGANISATION SUBMISSION PROCESS IN THE NATIONAL CENTRE FOR PHARMACOECONOMICS (NCPE), IRELAND

    Oct 1, 2018, 00:00

  • PHP25 - MENTAL HEALTH COMORBIDITIES AND ELEVATED RISK OF OPIOID USE IN ELDERLY BREAST CANCER SURVIVORS USING ADJUVANT ENDOCRINE TREATMENTS

    Oct 1, 2018, 00:00

  • PHP318 - EXPERIENCE WITH EARLY DIALOGUES (ED) IN EUNETHTA JA3

    Oct 1, 2018, 00:00

  • PSS18 - TREATMENT COSTS OF ATOPIC DERMATITIS IN KOREAN ADULTS ACCORDING TO DISEASE SEVERITY

    Oct 1, 2018, 00:00

  • PGI44 - PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) REPORT POSITIVE EXPERIENCE AFTER PARTICIPATING IN AN ONLINE QUANTITATIVE PREFERENCE SURVEY

    Oct 1, 2018, 00:00

  • PCN298 - MANAGEMENT OF ANTIEMETIC TREATMENT FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV)- PATIENTS’, ONCOLOGISTS’ AND NURSES’ PERSPECTIVES

    Oct 1, 2018, 00:00

  • DB1 - GLYCAEMIC CONTROL, CARDIOVASCULAR DISEASE AND MORTALITY IN TYPE 2 DIABETES (T2D) PATIENTS IN A REAL LIFE SETTING OVER TIME- POPULATION-BASED DATA FROM THE NETHERLANDS

    Oct 1, 2018, 00:00

  • PND9 - MIGRAINE BURDEN BEFORE AND AFTER ERENUMAB TREATMENT- A RESPONDER ANALYSIS IN DIFFICULT-TO-TREAT PATIENTS

    Oct 1, 2018, 00:00

  • PGI29 - GENDER DIFFERENCES IN CLINICAL PROFILE AND HEALTHCARE UTILIZATION OF NON ALCOHOLIC FATTY LIVER PATIENTS

    Oct 1, 2018, 00:00

  • CN1 - VALIDATING SURVIVAL EXTRAPOLATIONS IN FIRST LINE TREATMENT OF RENAL CELL CARCINOMA USING LITERATURE-BASED CONDITIONAL SURVIVAL PROBABILITIES

    Oct 1, 2018, 00:00

  • PMD36 - BUDGET IMPACT ANALYSIS OF THE USE OF LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA IN ITALY

    Oct 1, 2018, 00:00

  • PHP185 - BRAZIL'S ECONOMIC SITUATION AND THE EVOLUTION OF THE PRIVATE HEALTHCARE SYSTEM

    Oct 1, 2018, 00:00

  • PCV148 - A SYSTEMATIC LITERATURE REVIEW ON HEALTH STATE UTILITIES ASSOCIATED WITH NON-FATAL STROKE

    Oct 1, 2018, 00:00

  • PRM183 - DEVELOPMENT OF A FIT-FOR-PURPOSE TOBACCO AND NICOTINE PRODUCTS DEPENDENCE INSTRUMENT

    Oct 1, 2018, 00:00

  • PSY200 - PATIENT-REPORTED OUTCOMES MEASURES IN CHILDREN WITH SPINAL MUSCULAR ATROPHY

    Oct 1, 2018, 00:00

  • PCV154 - ASSESSING DIFFERENTIAL ATTRIBUTES OF DIRECT ORAL ANTICOAGULANTS WITH IMPACT ON PATIENT PREFERENCES. A PILOT STUDY

    Oct 1, 2018, 00:00

  • PCN319 - RCT NOT RWE- TWO YEAR REPORT CARD FOR THE CANCER DRUGS FUND REFORMS

    Oct 1, 2018, 00:00

  • PRS62 - PHARMACIST-LED SMOKING CESSATION SERVICES IN RESOURCE LIMITED SETTINGS- A CROSS-SECTIONAL AND SIMULATED STUDY IN ETHIOPIA

    Oct 1, 2018, 00:00

  • PDB133 - CHRONIC KIDNEY DISEASE, HEALTH MEASURES AND HEALTHCARE UTILIZATION AMONG ADULTS WITH DISBETES IN THE UNITED STATES

    Oct 1, 2018, 00:00

  • PMD96 - THE IMPACT OF STRUCTURAL ASSUMPTIONS ON DECISION UNCERTAINTY- A CASE STUDY ON THE PREVENTION OF NEONATAL INFECTIONS IN PRETERM BABIES

    Oct 1, 2018, 00:00

  • PCV55 - ECONOMIC BURDEN OF STROKE IN GERMANY- A SYSTEMATIC REVIEW

    Oct 1, 2018, 00:00

  • PRM251 - EVALUATING BUDGET IMPACT OF CURES. MACHINE LEARNING METHODS SHED LIGHT ON WHO CAN BE CURED IN METASTATIC MELANOMA

    Oct 1, 2018, 00:00

  • HT1 - CONSEQUENCES AND VALIDITY OF AN EMPIRICAL ESTIMATION OF THE NICE COST EFFECTIVENESS THRESHOLD

    Oct 1, 2018, 00:00

  • PRM203 - LINGUISTIC VALIDATION OF THE CHRONIC KIDNEY DISEASE AND ANAEMIA QUESTIONNAIRE (CKDAQ), A PATIENT REPORT OUTCOMES ASSESSMENT (PRO), INTO 30 ASIA-PACIFIC LANGUAGES

    Oct 1, 2018, 00:00

  • PND5 - A LITERATURE REVIEW REPORTING THE SIDE EFFECTS AND ANY RELATED CONSEQUENCES CAUSED BY CURRENT CHRONIC MYASTHENIA GRAVIS TREATMENTS

    Oct 1, 2018, 00:00

  • PMD145 - CHARACTERIZING BURDEN OF INTRAOPERATIVE AND EARLY POSTOPERATIVE PERIPROSTHETIC HIP FRACTURES FOLLOWING TOTAL HIP ARTHROPLASTY

    Oct 1, 2018, 00:00

  • PHP128 - 3F - FORMULA FOR FUNDING- RETHINKING THE PORTUGUESE HOSPITAL FUNDING SYSTEM

    Oct 1, 2018, 00:00

  • PHP120 - WHAT DO WE STAND TO LOSE? THE PROPORTION OF US-OWNED PHARMACEUTICALS ON AUSTRALIA’S PHARMACEUTICAL BENEFITS SCHEME

    Oct 1, 2018, 00:00

  • PND58 - COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH ABOBOTULINUMTOXINA COMPARED TO BEST SUPPORTIVE CARE IN PATIENTS WITH UPPER LIMB SPASTICITY IN SWEDEN

    Oct 1, 2018, 00:00

  • PCV149 - A SYSTEMATIC LITERATURE REVIEW (SLR) OF HEALTH STATE UTILITIES ASSOCIATED WITH NON-FATAL MYOCARDIAL INFARCTION (MI) OR ACUTE CORONARY SYNDROME (ACS)

    Oct 1, 2018, 00:00

  • PCN197 - COST UTILITY ANALYSIS OF FIRST-LINE PACLITAXEL WITH CARBOPLATIN AND BEVACIZUMAB FOLLOWED BY MAINTENANCE BEVACIZUMAB VERSUS PEMETREXED WITH CARBOPLATIN FOLLOWED BY MAINTENANCE PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SM ...

    Oct 1, 2018, 00:00

  • PCN346 - DISEASE SPECIFIC COST ANALYSIS OF THE NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER HEALTH STATES

    Oct 1, 2018, 00:00

  • PGI16 - THE ECONOMIC BURDEN OF CHRONIC INFLAMMATORY BOWEL DISEASE PATIENTS IN FINLAND

    Oct 1, 2018, 00:00

  • CN3 - VALUE OF ADJUVANT ONCOLOGY THERAPIES- METHODOLOGICAL CHALLENGES OF MODELLING COST-EFFECTIVENESS OF AN ADJUVANT TREATMENT IN AN ERA OF HIGH-COST ONCOLOGY TREATMENTS

    Oct 1, 2018, 00:00

  • PIN46 - COST-EFFECTIVENESS COMPARISON OF BALOXAVIR MARBOXIL AND LANINAMIVIR FOR THE TREATMENT OF INFLUENZA IN JAPAN

    Oct 1, 2018, 00:00

  • PMD8 - COMPARATIVE ASSESSMENT OF MEASURING TECHNIQUES OF CHILDREN’S TEMPERATURE IN PEDIATRIC DEPARTMENT

    Oct 1, 2018, 00:00

  • PSY113 - ASSESSMENT OF BASIC HEALTH TECHNOLOGIES FOR ACROMEGALY PHARMACOTHERAPY IN UKRAINE

    Oct 1, 2018, 00:00

  • PRM56 - COULD ERG PREFERENCES FOR DIFFERENT OVERALL SURVIVAL EXTRAPOLATION METHODOLOGIES DRIVE DIFFERENT NICE APPRAISAL OUTCOMES?

    Oct 1, 2018, 00:00

  • PRS11 - INITIATION OF TRIPLE THERAPY IN NEWLY DIAGNOSED COPD PATIENTS

    Oct 1, 2018, 00:00

  • CE2 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN

    Oct 1, 2018, 00:00

  • PCP57 - LIQUID BIOPSIES IN EARLY DETECTION OF BREAST CANCER, METASTATIC PROGRESSION AND THERAPY OUTCOMES- OPPORTUNITIES AND CHALLENGES FOR THE PERSPECTIVE OF PATIENTS, PROVIDERS AND PAYERS

    Oct 1, 2018, 00:00

  • PCN242 - HOW FAR DOES HIGH EXPENDITURE IMPLY EFFECTIVENESS? A STUDY OF THE RELATION BETWEEN ONCOLOGICAL DRUG EXPENDITURE AND HEALTH OUTCOMES FROM 37 COUNTRIES

    Oct 1, 2018, 00:00

  • PMS34 - THE IMPACT OF DISEASE DURATION AND DISEASE ACTIVITY ON THE COST OF RHEUMATOID ARTHRITIS IN SPAIN- RESULTS FROM BURDEN OF RHEUMATOID ARTHRITIS ACROSS EUROPE A SOCIOECONOMIC SURVEY (BRASS)

    Oct 1, 2018, 00:00

  • PDB55 - ECONOMIC ANALYSIS OF TYPE-2 DIABETES MELLITUS IN VIETNAM- A RETROSPECTIVE STUDY AT A DISTRICT HOSPITAL, BA RIA - VUNG TAU PROVINCE

    Oct 1, 2018, 00:00

  • PIN108 - HUMAN PAPILLOMAVIRUS VACCINATION UPTAKE BARRIERS AMONG ADOLESCENTS AND THEIR PARENTS IN THE RUSSIAN FEDERATION

    Oct 1, 2018, 00:00

  • PRM22 - SERVICE IMPACT MODELLING AS A TOOL TO SUPPORT MARKET ACCESS FOR HEALTH TECHNOLOGY INNOVATION

    Oct 1, 2018, 00:00

  • PGI39 - DARVADSTROCEL IN THE MANAGEMENT OF COMPLEX PERIANAL FISTULAS- THE ROLE OF PATIENT REGISTRY DATA COLLECTION TO SUPPORT PERFORMANCE-BASED RISK SHARING AGREEMENTS

    Oct 1, 2018, 00:00

  • PCN243 - POST-LOE PRICING DYNAMICS IN ONCOLOGY- IMPACT OF MANDATORY PRICE DISCOUNTS ON LIST PRICES AND GENERIC UPTAKE

    Oct 1, 2018, 00:00

  • PCN318 - CONDUCTING AND REPORTING INDIRECT TREATMENT COMPARISONS- A CRITICAL APPRAISAL OF ONCOLOGY TECHNOLOGY APPRAISALS

    Oct 1, 2018, 00:00

  • PMS1 - COMPARATIVE EFFECTIVENESS OF BARICITINIB VERSUS SARILUMAB IN RHEUMATOID ARTHRITIS- A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2018, 00:00

  • PCV82 - COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION IN SINGAPORE

    Oct 1, 2018, 00:00

  • PGI19 - STANDARD-DOSE PROTON PUMP INHIBITOR IN THE INITIAL NON-ERADICATION TREATMENT OF DUODENAL ULCER- SYSTEMATIC REVIEW, NETWORK META-ANALYSIS, AND COST-EFFECTIVENESS ANALYSIS

    Oct 1, 2018, 00:00

  • PDB116 - THE RELATIONSHIP BETWEEN POOR ADHERENCE AND HBA1C AND WEIGHT CHANGES IN PATIENTS WITH TYPE 2 DIABETES

    Oct 1, 2018, 00:00

  • PUK22 - ESTIMATES OF KIDNEY STONES COSTS. AN ANALYSIS OF CLINICAL AND ADMINISTRATIVE DATA TO MEASURE THE BURDEN OF KIDNEY STONES IN ITALY

    Oct 1, 2018, 00:00

  • PMH67 - COMPLIANCE WITH ANTIDEPRESSANT MEDICATION IN KOREA- A CROSS-SECTIONAL STUDY

    Oct 1, 2018, 00:00

  • PDB134 - CHARACTERISTICS OF US ADULTS WITH CONTROLLED AND UNCONTROLLED TYPE 2 DIABETES

    Oct 1, 2018, 00:00

  • PRM141 - COMPARISON OF NOVEL BAYESIAN METHODS USING EXTERNAL DATA TO IMPROVE SURVIVAL ESTIMATIONS FROM IMMATURE SURVIVAL DATA

    Oct 1, 2018, 00:00

  • PMS120 - THE IMPACT OF RHEUMATOID ARTHRITIS (RA) ON A PATIENT’S ABILITY TO WORK AND EARLY RETIREMENT DUE TO RA

    Oct 1, 2018, 00:00

  • PMH50 - TREATMENT OF OPIOID USE DISORDER IN ITALY- IS THERE SCOPE FOR POLICY CHANGE?

    Oct 1, 2018, 00:00

  • PCN125 - FIRST INSIGHTS INTO COMPARING EXPENDITURES FOR TARGETED THERAPY AND SURVIVAL IN NSCLC

    Oct 1, 2018, 00:00

  • PDB21 - COMPARATIVE EFFECTIVENESS OF SGLT2 INHIBITORS IN TYPE II DIABETES DERIVED FROM AN OVERVIEW OF 55 SYSTEMATIC REVIEWS

    Oct 1, 2018, 00:00

  • PMD3 - METHODS FOR QUANTIFYING POSTERIOR CAPSULAR OPACIFICATION AND THE IMPACT OF INTRAOCULAR LENS MATERIAL ON SEVERITY SCORES - A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2018, 00:00

  • PMS111 - PATIENTS’ PREFERENCES FOR TREATMENT OF PSORIATIC ARTHRITIS BASED ON A DISCRETE CHOICE EXPERIMENT. RESULTS OF THE COEPSO STUDY

    Oct 1, 2018, 00:00

  • PHP368 - THE FRENCH COMPASSIONATE USE OF MEDICINAL PRODUCTS PROGRAM (2012-2017)- HEALTH TECHNOLOGY ASSESSMENT AND PRICING IMPLICATIONS

    Oct 1, 2018, 00:00

  • PSY76 - ECONOMIC BURDEN OF DISEASES RELATED TO OVERWEIGHT AND OBESITY IN COLOMBIA

    Oct 1, 2018, 00:00

  • PSY197 - LIMITATIONS OF THE EQ5D INSTRUMENT IN THE ASSESSMENT OF QUALITY OF LIFE IN CHRONIC RARE DISEASES – A CASE STUDY FROM FCS

    Oct 1, 2018, 00:00

  • PMS113 - TOWARD PATIENT-CENTERED VALUE ASSESSMENT- LESSONS FROM THE IVI OPEN-SOURCE VALUE PROJECT

    Oct 1, 2018, 00:00

  • PMU70 - PRESCRIPTION ANALYSIS OF HYPOCALORIC PERIPHERAL PARENTERAL NUTRITION AT A TERTIARY CARE HOSPITAL

    Oct 1, 2018, 00:00

  • PIH44 - OLDER PEOPLE WITH LONG TERM CONDITIONS USING TECHNOLOGIES SUPPORTING HOME BASED CARE- PATTERNS OF RESOURCE USE, COSTS AND HEALTH RELATED QUALITY OF LIFE

    Oct 1, 2018, 00:00

  • PCN46 - DURABLE THERAPY IN FRONTLINE CLL IMPROVES OS

    Oct 1, 2018, 00:00

  • PIN86 - COST SAVINGS TO BE EXPECTED FROM THE INTRODUCTION OF NEW ANTI-HIV GENERICS IN UNIVERSITY PUBLIC HOSPITALS OF PARIS

    Oct 1, 2018, 00:00

  • PDB92 - PHYSICIANS’ ADHERENCE TO CLINICAL PRACTICE GUIDELINES IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS ELDERLY PATIENTS. THE IMPLICA2 STUDY

    Oct 1, 2018, 00:00

  • PMH34 - A CONCEPTUAL ECONOMIC MODEL FOR DIGITAL INTERVENTIONS IN SERIOUS MENTAL ILLNESS

    Oct 1, 2018, 00:00

  • PUK37 - USE OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) INSTRUMENTS IN CLINICAL TRIALS OF ANAEMIA OF CHRONIC KIDNEY DISEASE (CKD)

    Oct 1, 2018, 00:00

  • PCV124 - HOSPITAL ADMISSIONS FOR HEART FAILURE IN ENGLAND; AN INCREASING BURDEN ON NHS RESOURCES AND THE FOCUS OF EFFECTIVE COST CONTAINMENT

    Oct 1, 2018, 00:00

  • PDB98 - TYPE 2 DIABETES- REAL-LIFE STUDY BASED ON SNIIRAM DATA OF PATIENTS INITIATING AGLP1 IN 2016

    Oct 1, 2018, 00:00

  • PHP114 - THE ERRATIC AND LONG ACCESS JOURNEY OF ORPHAN DRUGS FROM EUROPE TO PORTUGAL

    Oct 1, 2018, 00:00

  • PCV46 - PHARMACOECONOMIC EVALUATION AND BUDGET IMPACT ANALYSIS OF IVABRADINE IN CHINA

    Oct 1, 2018, 00:00
  • «
  • 51
  • 52 (current)
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • »